DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE

DIAGNOSING DIGOXIN TOXICITY BY COMBINED MEASUREMENT OF PLASMA DIGOXIN CONCENTRATIONS AND ERYTHROCYTIC RB-86 UPTAKE

Opis bibliograficzny
Główni autorzy:	Aronson, J, Carver, J
Format:	Journal article
Wydane:	1983

Podobne zapisy

Monitoring digoxin therapy. The use of plasma digoxin concentration measurements in the diagnosis of digoxin toxicity.
od: Aronson, J, i wsp.
Wydane: (1978)

Indications for the measurement of plasma digoxin concentrations.
od: Aronson, J
Wydane: (1983)

The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.
od: Ford, A, i wsp.
Wydane: (1979)

Interaction of digoxin with quinine.
od: Aronson, J, i wsp.
Wydane: (1981)

Digoxin revisited.
od: Aronson, J
Wydane: (1998)

ERYTHROCYTIC DIGOXIN RECEPTOR NUMBERS AND ACTIVITY - RELATION TO CLINICAL CHANGES FOLLOWING DIGOXIN WITHDRAWAL AFTER LONG-TERM TREATMENT FOR HEART-FAILURE IN SINUS RHYTHM
od: Pugh, S, i wsp.
Wydane: (1982)

The characteristics of the binding of 12-alpha-[3H]-digoxin to the membranes of intact human erythrocytes: relevance to digoxin therapy.
od: Ford, A, i wsp.
Wydane: (1979)

Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.
od: Ford, A, i wsp.
Wydane: (1979)

The use of colour vision measurement in the diagnosis of digoxin toxicity.
od: Aronson, J, i wsp.
Wydane: (1980)

Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity
od: Sophia Sheikh, i wsp.
Wydane: (2024-06-01)

Clinical pharmacokinetics of digoxin 1980.
od: Aronson, J
Wydane: (1980)

MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
od: S. F. Zadvorev, i wsp.
Wydane: (2018-05-01)

ABC of monitoring drug therapy. Digoxin.
od: Aronson, J, i wsp.
Wydane: (1992)

Monitoring digoxin therapy: I. Plasma concentrations and an in vitro assay of tissue response.
od: Aronson, J, i wsp.
Wydane: (1977)

Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
od: Antonella Colella, i wsp.
Wydane: (2022-06-01)

Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody
od: Farzad Gheshlagh, i wsp.
Wydane: (2021-01-01)

Monitoring digoxin therapy: III. How useful are the nomograms?
od: Aronson, J
Wydane: (1978)

Digoxin-like factor in infants of diabetic mothers not receiving digoxin therapy
od: M Yurdakök, i wsp.
Wydane: (1989-10-01)

Efficiency of individual dosage of digoxin with calculated concentration
od: Zhao L, i wsp.
Wydane: (2014-07-01)

A study of the transport of lithium across the erythrocyte membrane in vivo and of the effects of the ion transport inhibitors digoxin and dipyridamole.
od: Wood, A, i wsp.
Wydane: (1989)

Monitoring digoxin therapy: II. Determinants of the apparent volume of distribution.
od: Aronson, J, i wsp.
Wydane: (1977)

Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
od: Zeynep ÖZTÜRK, i wsp.
Wydane: (2018-01-01)

Appropriateness of digoxin level monitoring
od: MR Mordasini, i wsp.
Wydane: (2002-09-01)

Neglected facts in digoxin intoxication
od: Sibel Ocak Serin
Wydane: (2017-06-01)

THE EFFECT OF DIGOXIN ON THE INVIVO DISPOSITION OF AN ORAL LOAD OF RUBIDIUM CHLORIDE
od: Aronson, J, i wsp.
Wydane: (1982)

Treatment with Digoxin – is it a clinical challenge? A Retrospective Analysis of Hospitalizations due to Digoxin intoxication
od: Marcin Wais, i wsp.
Wydane: (2024-04-01)

Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
od: Tadej Petreski, i wsp.
Wydane: (2023-08-01)

Clinical signs and symptoms of toxic serum digoxin levels in neonates
od: Mehmet Mutlu, i wsp.
Wydane: (2019-04-01)

Study the toxicity of digoxin on liver and their transaminase enzymes level in rat
od: Abbas Khadhair, i wsp.
Wydane: (2017-12-01)

Digoxin for Atrial Fibrillation in Spinal Anesthesia
od: Maryam Vosoughian, i wsp.
Wydane: (2024-03-01)

Preparation of Nanoparticles of Digoxin Solid Lipid
od: Ping Luo, i wsp.
Wydane: (2017-12-01)

Inadvertent Intrathecal Administration of Digoxin, with Review of the Literature
od: Burton J. Tabaac, i wsp.
Wydane: (2023-01-01)

Unmasking the Role of Uptake Transporters for Digoxin Uptake Across the Barriers of the Central Nervous System in Rat
od: Kunal S Taskar, i wsp.
Wydane: (2017-03-01)

In vivo cation transport during short-term and long-term digoxin therapy.
od: Boon, N, i wsp.
Wydane: (1986)

The effect of cholestyramıne on dogs with acute digoxin toxicosis
od: Abdullah Başoğlu, i wsp.

Digoxin and Heart Failure: Are We Clear Yet?
od: Amit Gupta, i wsp.
Wydane: (2017-04-01)

An HPLC method for the determination of digoxin in dissolution samples
od: Milenković Miroslav Ž., i wsp.
Wydane: (2010-01-01)

EFFICACY OF DIGOXIN IN THE MANAGEMENT OF IDIOPATHIC CARDIOMYOPATHY IN DOGS
od: R. Vijayan, i wsp.
Wydane: (2003-01-01)

A DNA-Based Assay for Digoxin Detection
od: Michael V. Kjelstrup, i wsp.
Wydane: (2018-03-01)

EFFICACY OF DIGOXIN IN THE MANAGEMENT OF IDIOPATHIC CARDIOMYOPATHY IN DOGS
od: R. Vijayan, i wsp.
Wydane: (2014-01-01)